H. Hanabusa

发表

Nonacog beta pegol (N9-GP) in haemophilia B: A multinational phase III safety and efficacy extension trial (paradigm™4).

J. Oldenburg, A. Chuansumrit, E. Santagostino, 2016, Thrombosis research.

Nonacog beta pegol in previously treated children with hemophilia B: results from an international open‐label phase 3 trial

E. Santagostino, M. Carcao, S. Rangarajan, 2016, Journal of thrombosis and haemostasis : JTH.

Brief Report: The Impact of Ledipasvir/Sofosbuvir on HIV-Positive and HIV-Negative Japanese Hemophilia Patients With 1, 4, and Mixed-Genotype HCV

H. Hanabusa, A. Nagao, 2017, Journal of acquired immune deficiency syndromes.

Clinical evaluation of glycoPEGylated recombinant FVIII: Efficacy and safety in severe haemophilia A

P. Giangrande, J. Oldenburg, E. Santagostino, 2016, Thrombosis and Haemostasis.

Recombinant long‐acting glycoPEGylated factor IX (nonacog beta pegol) in haemophilia B: assessment of target joints in multinational phase 3 clinical trials

C. Négrier, G. Young, P. Collins, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

Safety and efficacy of a glycoPEGylated rFVIII (turoctocog alpha pegol, N8-GP) in paediatric patients with severe haemophilia A

J. Staber, S. Meunier, O. Stasyshyn, 2017, Thrombosis and Haemostasis.

Mucocutaneous Manifestations in Japanese HIV-Positive Hemophiliacs

H. Hanabusa, Ko-Ron Chen, S. Shimizu, 2000, Dermatology.

Prediction of the efficacy of antiviral therapy for hepatitis C virus infection by an ultrasensitive RT‐PCR assay

S. Kato, E. Kinai, H. Hanabusa, 2007, Journal of medical virology.

Factor VIII-Mimetic Function of Humanized Bispecific Antibody in Hemophilia A.

Tetsuji Sato, K. Yoneyama, T. Matsushita, 2016, The New England journal of medicine.

Renal tubular toxicity associated with tenofovir assessed using urine-beta 2 microglobulin, percentage of tubular reabsorption of phosphate and alkaline phosphatase levels

E. Kinai, H. Hanabusa, 2005, AIDS.

Clinical pharmacological study of a plasma‐derived factor VIIa and factor X mixture (MC710) in haemophilia patients with inhibitors – Phase I trial

Y. Ohashi, J. Takamatsu, A. Shirahata, 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

Clinical Trial to Investigate the Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy of Recombinant Factor VIIa in Japanese Patients With Hemophilia With Inhibitors

S. Fujita, J. Takamatsu, J. Kamizono, 2001, International journal of hematology.

Interleukin 18 and interleukin 1beta production is decreased in HIV type 1-seropositive hemophiliacs but not in HIV type 1-seropositive nonhemophiliacs.

H. Okamura, M. Ikeda, M. Kurimoto, 2000, AIDS research and human retroviruses.

Evaluation of the safety, pharmacokinetics, and efficacy of recombinant factor VIII fc fusion protein in Japanese subjects with severe haemophilia A: analysis from the A-LONG study

T. Matsushita, K. Nogami, M. Taki, 2016 .

Clinical practice guidelines for the diagnosis and management of patients with acquired hemophilia A approved by The Japanese Society on Thrombosis and Hemostasis

Y. Toyama, J. Mimuro, J. Takamatsu, 2011 .

A Phase II clinical trial of a mixture of plasma‐derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors: haemostatic efficacy, safety and pharmacokinetics/pharmacodynamics

Y. Ohashi, J. Takamatsu, H. Mugishima, 2013, Haemophilia.

Results of clot waveform analysis and thrombin generation test for a plasma‐derived factor VIIa and X mixture (MC710) in haemophilia patients with inhibitors—phase I trial: 2nd report

Y. Ohashi, J. Takamatsu, A. Shirahata, 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

Effects of Pentoxifylline on Polymorphonuclear Leukocyte Function

T. Kuratsuji, S. Shimizu, Y. Ichihashi, 1985 .

An evaluation of semen processing methods for eliminating HIV-1

S. Kato, N. Kuji, Y. Yoshimura, 2000, AIDS.

Progressive renal tubular dysfunction associated with long-term use of tenofovir DF.

E. Kinai, H. Hanabusa, 2009, AIDS research and human retroviruses.

Short-term efficacy of the IL6 receptor antibody tocilizumab in patients with HIV-associated multicentric Castleman disease: report of two cases

S. Nakazawa, H. Hanabusa, A. Nagao, 2014, Journal of Hematology & Oncology.

A 3-year consecutive survey on current status of acquired inhibitors against coagulation factors in Japan

J. Takamatsu, A. Shirahata, T. Matsushita, 2008 .

Clinical haemophilia Long-term safety and efficacy of recombinant factor VIII Fc fusion protein ( rFVIIIFc ) in subjects with haemophilia

D. Perry, B. Konkle, K. Pasi, 2016 .

Long-Term Safety and Efficacy of Recombinant Factor VIII FC (RFVIIIFC) in Adults and Adolescents With Severe Haemophilia A: An Interim Analysis of The ASPIRE Study

D. Perry, B. Konkle, J. Mahlangu, 2015 .

Japanese subject subpopulation analysis of B-LONG: a Phase 3 study of long-acting recombinant factor IX Fc fusion protein

T. Matsushita, M. Taki, M. Shima, 2015 .

Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial.

E. Santagostino, L. Boggio, C. Négrier, 2016, Blood.

Recombinant factor VIII Fc fusion protein: extended‐interval dosing maintains low bleeding rates and correlates with von Willebrand factor levels

J. Dumont, I. Nestorov, D. Quon, 2014, Journal of thrombosis and haemostasis : JTH.

Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A.

J. Dumont, I. Nestorov, D. Perry, 2014, Blood.

Post hoc analysis to evaluate the effect of recombinant factor IX Fc fusion protein (rFIXFc) prophylaxis in adults and adolescents with target joints and hemophilia B

K. Pasi, R. Liesner, N. Jain, 2016 .

Long-term safety and efficacy of emicizumab in a phase 1/2 study in patients with hemophilia A with or without inhibitors.

Tetsuji Sato, K. Yoneyama, T. Matsushita, 2017, Blood advances.

A multi-center survey of hospital charges for hemophilia and the related diseases in Japan

K. Amano, M. Shima, S. Higasa, 2006 .

Analysis of the Japanese subgroup in LEOPOLD II: a phase 2/3 study of BAY 81-8973, a new recombinant factor VIII product

M. Shima, K. Fukutake, H. Hanabusa, 2017, International Journal of Hematology.

Long‐term safety and efficacy of recombinant factor VIII Fc fusion protein (rFVIIIFc) in subjects with haemophilia A

D. Perry, B. Konkle, K. Pasi, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

hemophilia A Phase 3 study of recombinant factor VIII Fc fusion protein in severe

J. Dumont, I. Nestorov, D. Perry, 2014 .

Sub analysis of Japanese patients with hemophilia B in rIX-FP clinical trial

Koji Yamamoto, T. Matsushita, K. Nogami, 2017 .

Safety and Prophylactic Efficacy Profiles of ACE910, a Humanized Bispecific Antibody Mimicking the FVIII Cofactor Function, in Japanese Hemophilia A Patients Both without and with FVIII Inhibitors: First-in-Patient Phase 1 Study

Tetsuji Sato, K. Yoneyama, T. Matsushita, 2014 .

Clinical pathway in outpatient management of haemophilia

H. Hanabusa, A. Nagao, Kenichi Kojima, 2014 .

Outcome of the Japanese Immune Tolerance Induction (ITI) Registry and Predictors of Successful ITI

S. Ohga, T. Matsushita, K. Nogami, 2015 .

A phase III clinical trial of a mixture agent of plasma‐derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors

Y. Ohashi, J. Takamatsu, H. Mugishima, 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

Clinical Study of Recombinant Factor VIIa (NN-007) in Hemophilia Patients with Inhibitors

J. Takamatsu, H. Saito, A. Shirahata, 1994 .

Safety, Efficacy and Pharmacokinetics of Nonacog Beta Pegol (N9-GP) in Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Pediatric Hemophilia B Patients

E. Santagostino, M. Carcao, S. Rangarajan, 2014 .

Safety and Efficacy of Nonacog Beta Pegol (N9-GP) for Prophylaxis and Treatment of Bleeding Episodes in Previously-Treated Patients with Hemophilia B: Results from an Extension Trial

J. Oldenburg, A. Chuansumrit, E. Santagostino, 2014 .

Safety and efficacy of B-domain truncated recombinant factor VIII in previously treated patients with hemophilia A: Comparison of data between total population and Japanese subject population

Y. Sakata, T. Matsushita, K. Nogami, 2014 .

Long-Term Safety and Efficacy of rFVIIIFc in Adults and Adolescents with Severe Hemophilia A: A Longitudinal Analysis of A-LONG and ASPIRE

D. Perry, B. Konkle, K. Pasi, 2015 .

Inversion in Japanese Patients with Hemophilia A

K. Fukutake, H. Inaba, T. Nagao, 1995, Thrombosis and Haemostasis.

Increasing genetic diversity of hepatitis C virus in haemophiliacs with human immunodeficiency virus coinfection.

T. Gojobori, Kousuke Hanada, M. Mizokami, 2007, The Journal of general virology.

Efficacy of induction therapy with high-dose interferon for patients with hemophilia and human immunodeficiency virus-hepatitis C virus coinfection.

H. Hanabusa, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical efficacy of a combination of Percoll continuous density gradient and swim-up techniques for semen processing in HIV-1 serodiscordant couples

T. Hamatani, K. Isaka, S. Kato, 2016, Asian journal of andrology.

Separation of human immunodeficiency virus type 1 (HIV-1) from motile sperm using a continuous density gradient and subsequent swim-up

S. Kato, N. Kuji, Y. Yoshimura, 2011 .

Buoyant density and sedimentation dynamics of HIV-1 in two density-gradient media for semen processing.

T. Hamatani, S. Kato, N. Kuji, 2008, Fertility and sterility.

Complete removal of HIV-1 RNA and proviral DNA from semen by the swim-up method: assisted reproduction technique using spermatozoa free from HIV-1

Kenichi Tanaka, K. Takakuwa, M. Iwashita, 2006, AIDS.

Prevalence of drug resistance-related mutations among HIV-1s in Japan.

S. Kashiwagi, W. Sugiura, J. Takamatsu, 1999, Japanese journal of infectious diseases.

Absence of anti-human herpesvirus 8 antibody in 32 Japanese hemophiliacs with advanced HIV infection

H. Shimizu, T. Sata, H. Katano, 2001, Archives of Dermatological Research.

A Novel Mutation Glyl672→Arg in Type 2A and a Homozygous Mutation in Type 2B von Willebrand Disease

S. Yoshida, K. Fukutake, H. Inaba, 1996, Thrombosis and Haemostasis.

Renal atrophy associated with long-term treatment with indinavir.

H. Hataya, H. Hanabusa, H. Tagami, 1999, The New England journal of medicine.

HLA-B polymorphism in Japanese HIV-1-infected long-term surviving hemophiliacs.

S. Oka, A. Kimura, M. Taki, 2005, Viral immunology.

Kawasaki disease, oxygen radicals and high dose gammaglobulin therapy.

T. Kuratsuji, H. Hanabusa, T. Ojima, 1988, Basic life sciences.

Assisted Reproduction Techniques for HIV Positive Couples

H. Hanabusa, 2007 .

Evaluation of HIV Transmisson Risk Reduction in Artificial Insemination and IVF with Spermatozoa Prepared by Percoll Gradient Centrifugation and Swim Up

H. Hanabusa, 2001 .

Instructions for use Title Elicitation of Both Anti HIV-1 Env Humoral and Cellular Immunities by Replicating Vaccinia PrimeSendai Virus Boost Regimen and Boosting by CD 40 Lm Author ( s )

Kazunori Kato, T. Ohashi, T. Shioda, 2017 .

Elicitation of Both Anti HIV-1 Env Humoral and Cellular Immunities by Replicating Vaccinia Prime Sendai Virus Boost Regimen and Boosting by CD40Lm

Kazunori Kato, T. Ohashi, T. Shioda, 2012, PloS one.

[Prospective matched control study concerning the treatment and quality of life of hemophiliacs with inhibitors].

H. Mohri, J. Takamatsu, A. Shirahata, 1998, [Rinsho ketsueki] The Japanese journal of clinical hematology.

Detection of cytomegalovirus (CMV) antigen for rapid diagnosis and monitoring of CMV diseases in AIDS

H. Nomori, Y. Minamishima, T. Minematsu, 1994 .

Acquired hemophilia A and fulminant diabetes mellitus possibly caused by adalimumab in a patient with psoriatic arthritis

H. Nakagawa, Y. Umezawa, M. Itoh, 2017, The Journal of dermatology.

Studies of assisted reproduction techniques (ART) for HIV-1-discordant couples using washed sperm and the nested PCR method: a comparison of the pregnancy rates in HIV-1-discordant couples and control couples.

Kenichi Tanaka, K. Takakuwa, S. Kato, 2009, Japanese journal of infectious diseases (Print).

Differential prevalence of HIV type 1 subtype B and CRF01_AE among different sexual transmission groups in Tokyo, Japan, as revealed by subtype-specific PCR.

M. Negishi, S. Kato, Rie Saito, 2003, AIDS research and human retroviruses.

POSTER VIEWING SESSION - FEMALE (IN) FERTILITY

S. Campbell, H. Steiner, B. Mol, 2011 .

Intracellular Efavirenz Levels in Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus-Infected Individuals

N. Hasegawa, M. Negishi, S. Kato, 2007, Antimicrobial Agents and Chemotherapy.

Long-Term Efficacy and Quality of Life with Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) Prophylaxis in Pediatric, Adolescent, and Adult Subjects with Target Joints and Severe Hemophilia a

B. Kerlin, Michael Wang, S. Lethagen, 2016 .

Prophylaxis vs. on-demand treatment with BAY 81-8973, a full-length plasma protein-free recombinant factor VIII product: results from a randomized trial (LEOPOLD II)

J. Mahlangu, Depei Wu, C. Truica, 2015, Journal of thrombosis and haemostasis : JTH.